DLA Piper has advised the shareholders of Symphar sp. z o.o. on the deal. Symphar sp. z o.o., a leading Polish pharmaceutical business, announced the sale...
DLA Piper has advised the shareholders of Symphar sp. z o.o. on the deal. Symphar sp. z o.o., a leading Polish pharmaceutical business, announced the sale...
